Correlation Between Vor Biopharma and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vor Biopharma and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vor Biopharma and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vor Biopharma and Edgewise Therapeutics, you can compare the effects of market volatilities on Vor Biopharma and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vor Biopharma with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vor Biopharma and Edgewise Therapeutics.
Diversification Opportunities for Vor Biopharma and Edgewise Therapeutics
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Vor and Edgewise is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Vor Biopharma and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Vor Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vor Biopharma are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Vor Biopharma i.e., Vor Biopharma and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Vor Biopharma and Edgewise Therapeutics
Considering the 90-day investment horizon Vor Biopharma is expected to generate 2.34 times more return on investment than Edgewise Therapeutics. However, Vor Biopharma is 2.34 times more volatile than Edgewise Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 73.00 in Vor Biopharma on August 28, 2024 and sell it today you would earn a total of 9.00 from holding Vor Biopharma or generate 12.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vor Biopharma vs. Edgewise Therapeutics
Performance |
| Timeline |
| Vor Biopharma |
| Edgewise Therapeutics |
Vor Biopharma and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vor Biopharma and Edgewise Therapeutics
The main advantage of trading using opposite Vor Biopharma and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vor Biopharma position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Vor Biopharma vs. Monte Rosa Therapeutics | Vor Biopharma vs. Design Therapeutics | Vor Biopharma vs. Erasca Inc | Vor Biopharma vs. Edgewise Therapeutics |
| Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. HCW Biologics | Edgewise Therapeutics vs. Scpharmaceuticals | Edgewise Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |